Three tiny publicly traded companies — SciSparc, Clearmind, and VINCE Holding — regularly put out press releases using psychedelic buzzwords. Within the next nine weeks, at least one of them is expected to do something that hurts regular investors: issue lots of new shares (dilution), do a reverse stock split to avoid being delisted, or make a flashy announcement that's more marketing than real science.
6-K/8-K 'psychedelic' mentions from micro-caps are almost always financing theater. Institutional capital ignores these. Follow the cash burn, not the buzzword.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →